Novel anti-inflammatory effects of repaglinide in rodent models of inflammation

Pharmacology

Volumn 88, Issue 5-6, 2011, Pages 295-301

  Tung, David ^a   Cheung, Peter H ^a   Ciallella, John ^b   Saha, Saurabh ^a  

^a BioMed Valley Discoveries   (United States)

^b Melior Discovery Inc   (United States)

Author keywords

Anti inflammation; Hyperreactivity; Immunomodulation; Lipopolysaccharide challenge; Repaglinide

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; DEXAMETHASONE; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; REPAGLINIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIZATION; ERYTHROCYTE; FOOT PAD; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SHEEP; SWELLING; TRACHEOBRONCHIAL TOILET;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARBAMATES; CHEMOKINE CCL2; DINITROFLUOROBENZENE; EAR; ERYTHROCYTES; FOOT; HYPERSENSITIVITY, DELAYED; IMMUNOLOGIC FACTORS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED ICR; PIPERIDINES; PNEUMONIA; SHEEP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80855144259     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000333793     Document Type: Article

References (44)

1. Balfour JA, Faulds D: Repaglinide. Drugs Aging 1998; 13: 173-180.
2. Malaisse WJ: Insulinotropic action of meglitinide analogues: Modulation by an activation of ATP-sensitive K + channels and high extracellular K + concentrations. Pharmacol Res 1995; 32: 111-114. (Pubitemid 26048778)
3. Gromada J, Dissing S, Kofod H, Frokjaer- Jensen J: Effects of the hypoglycaemic drugs repaglinide and glibenclamide on potassium- channels and cytosolic calcium levels in beta TC3 cells and pancreatic beta cells. Diabetologia 1995; 38: 1025-1032.
4. Laghmich A, Ladriere L, Malaisse-Lagae F, Malaisse WJ: Pancreatic islet responsiveness to D -glucose after repeated repaglinide. Eur J Pharmacol 1998; 348: 265-270. (Pubitemid 28275591)
5. Leclercq-Meyer V, Ladriere L, Fuhlendorff J, Malaisse WJ: Stimulation of insulin and somatostatin release by two meglitinide analogs. Endocrine 1997; 7: 311-317. (Pubitemid 28223937)
6. Malaisse WJ: Stimulation of insulin release by non-sulfonylurea hypoglycemic agents: Meglitinide family. Horm Metab Res 1995; 27: 263-266.
7. Esposito K, Giugliano D, Nappo F, Marfella R: Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004; 110: 214-219. (Pubitemid 38924590)
8. Tankova T, Koev D, Dakovska L, Kirilov G: The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract 2003; 59: 43-49. (Pubitemid 35461909)
9. Lund SS, Tarnow L, Stehouwer CD, Schalkwijk CG, Teerlink T, Gram J, et al: Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. Eur J Endocrinol 2008; 158: 631-641. (Pubitemid 351639600)
10. Gumieniczek A, Hopkala H, Rolinski J, Bojarska- Junak A: Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals. Pharmacol Res 2005; 52: 162-166. (Pubitemid 40828367)
11. Nagai H, Ueda Y, Ochi T, Hirano Y, Tanaka H, Inagaki N, et al: Different role of IL-4 in the onset of hapten-induced contact BALB/c and C57BL/6 mice. Br J Pharmacol 2000; 129: 299-306. (Pubitemid 30072650)
12. Nagai H, Hiyama H, Matsuo A, Ueda Y, Inagaki N, Kawada K: FK-506 and cyclosporin A potentiate the IgE antibody production by sensitization with hapten in mice. J Pharmacol Exp Ther 1997; 283: 321-327. (Pubitemid 27438977)
13. Nagai H, Matsuo A, Hiyama H, Inagaki N, Kawada K: Immunoglobulin E production in mice by means of contact sensitization with a simple chemical, hapten. J Allergy Clin Immunol 1997; 100:S39-44.
14. Abe M, Kondo T, Xu H, Fairchild RL: Interferon- gamma inducible protein (IP-10) expression is mediated by and is regulated by CD4+ T cells during the elicitation of contact hypersensitivity. J Invest Dermatol 1996; 107: 360-366. (Pubitemid 26284344)
15. Riemann H, Schwarz A, Grabbe S, Aragane Y, Luger TA, Wysocka M, et al: Neutralization of IL-12 in vivo prevents induction of contact and induces hapten-specific tolerance. J Immunol 1996; 156: 1799-1803. (Pubitemid 26069312)
16. Xu B, Aoyama K, Kitani A, Yu S, Matsuyama T, Matsushita T: Interleukin-12 enhances contact hypersensitivity by modulating the in vivo cytokine pattern in mice. J Interferon Cytokine Res 1998; 18: 23-31. (Pubitemid 28084073)
17. Xu H, DiIulio NA, Fairchild RL: T cell populations primed by hapten sensitization in contact distinguished by polarized patterns of cytokine production: Interferon gammaproducing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996; 183: 1001-1012.
18. Hong YH, Chao WW, Chen ML, Lin BF: Ethyl acetate extracts of alfalfa ( Medicago sativa L.) sprouts inhibit lipopolysaccharide-induced inflammation in vitro and in vivo. J Biomed Sci 2009; 16: 64.
19. Jeong YI, Jung ID, Lee CM, Chang JH, Chun SH, Noh KT, et al: The novel role of plateletactivating factor in protecting mice against lipopolysaccharide-induced endotoxic shock. PLoS One 2009; 4:e6503.
20. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ: Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169: 1485-1490. (Pubitemid 19104979)
21. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ: Human monocyte chemoattractant protein-1 (MCP-1). Fulllength cDNA expression in mitogen-stimulated blood mononuclear leukocytes, and similarity to mouse competence gene JE. FEBS Lett 1989; 244: 487-493. (Pubitemid 19067175)
22. Rollins BJ: Monocyte chemoattractant protein 1: A potential regulator of monocyte in inflammatory disease. Mol Med Today 1996; 2: 198-204. (Pubitemid 126401890)
23. Handel TM, Johnson Z, Rodrigues DH, Dos Santos AC, Cirillo R, Muzio V, et al: An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. J Leukoc Biol 2008; 84: 1101-1108.
24. Takahashi M, Galligan C, Tessarollo L, Yoshimura T: Monocyte chemoattractant protein- 1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J Immunol 2009; 183: 3463-3471.
25. Pickup JC, Chusney GD, Thomas SM, Burt D: Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000; 67: 291-300. (Pubitemid 30413937)
26. Kado S, Nagase T, Nagata N: Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetol 1999; 36: 67-72.
27. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation 2002; 106: 2067-2072. (Pubitemid 35192812)
28. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P: Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab 2000; 85: 2572-2575. (Pubitemid 32269217)
29. Natella F, Nardini M, Di Felice M, Scaccini C: Benzoic and cinnamic acid derivatives as antioxidants: Structure-activity relation. J Agric Food Chem 1999; 47: 1453-1459. (Pubitemid 29217138)
30. Haseloff RF, Blasig IE, Meffert H, Ebert B: Hydroxyl radical scavenging and antipsoriatic activity of benzoic acid derivatives. Free Radic Biol Med 1990; 9: 111-115.
31. Naha PC, Davoren M, Lyng FM, Byrne HJ: Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells. Toxicol Appl Pharmacol 2010; 246: 91-99.
32. Seo JY, Kim H, Seo JT, Kim KH: Oxidative stress induced cytokine production in isolated rat pancreatic acinar cells: Effects of small-molecule antioxidants. Pharmacology 2002; 64: 63-70. (Pubitemid 34114191)
33. Reddy DB, Reddanna P: Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages. Biochem Biophys Res Commun 2009; 381: 112-117.
34. Hall S, Turcato S, Clapp L: Abnormal activation of K + channels underlies relaxation to bacterial lipopolysaccharide in rat aorta. Biochem Biophys Res Commun 1996; 224: 184-190. (Pubitemid 26252431)
35. Cauwels A, Rogge E, Janssen B, Brouckaert P: Reactive oxygen species and small-conductance calcium-dependent potassium channels are key mediators of inflammation- induced hypotension and shock. J Mol Med 2010; 88: 921-930.
36. Kuo JH, Chen SJ, Shih CC, Lue WM, Wu CC: Abnormal activation of potassium channels in aortic smooth muscle of rats with peritonitis- induced septic shock. Shock 2009; 32: 74-79.
37. Cauwels A, Brouckaert P: Critical role for small and large conductance calcium-dependent potassium channels in endotoxemia and TNF toxicity. Shock 2008; 29: 577-582. (Pubitemid 351544077)
38. Spiller F, Orrico MI, Nascimento DC, Czaikoski PG, Souto FO, Alves-Filho JC, et al: Hydrogen sulfide improves neutrophil migration and survival in sepsis via K + ATP channel activation. Am J Respir Crit Care Med 2010; 182: 360-368.
39. Malerba M, Radaeli A, Mancuso S, Polosa R: The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease. J Biol Regul Homeost Agents 2010; 24: 123-130.
40. Akbarali HI, Pothoulakis C, Castagliuolo I: Altered ion channel activity in murine colonic smooth muscle myocytes in an experimental colitis model. Biochem Biophys Res Commun 2000; 275: 637-642.
41. d'Emmanuele di Villa Bianca R, Lippolis L, Autore G, Popolo A, Marzocco S, Sorrentino L, et al: Dexamethasone improves vascular hyporeactivity induced by LPS in vivo by modulating ATP-sensitive potassium channels activity. Br J Pharmacol 2003; 140: 91-96. (Pubitemid 37175834)
42. da Silva-Santos JE, Terluk MR, Assreuy J: Differential involvement of guanylate cyclase and potassium channels in nitric oxideinduced hyporesponsiveness to phenylephrine in endotoxemic rats. Shock 2002; 17: 70-76.
43. Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis. Crit Care Med 1987; 15: 923-929. (Pubitemid 18055700)
44. Da Silva-Santos JE, Santos-Silva MC, Cunha Fde Q, Assreuy J: The role of ATP-sensitive potassium channels in neutrophil migration and plasma exudation. J Pharmacol Exp Ther 2002; 300: 946-951. (Pubitemid 34165000)